Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong · Delayed Price · Currency is HKD 6.78
+0.20 (3.04%)
At close: Mar 27, 2026
HKG:0512 Revenue
In the year 2025, Grand Pharmaceutical Group had annual revenue of 12.28B HKD with 5.48% growth. Grand Pharmaceutical Group had revenue of 6.18B in the half year ending December 31, 2025, with 36.03% growth.
Revenue
12.28B
Revenue Growth
+5.48%
P/S Ratio
1.93
Revenue / Employee
987.40K
Employees
12,440
Market Cap
23.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.28B | 638.38M | 5.48% |
| Dec 31, 2024 | 11.64B | 1.12B | 10.59% |
| Dec 31, 2023 | 10.53B | 967.31M | 10.12% |
| Dec 31, 2022 | 9.56B | 964.31M | 11.22% |
| Dec 31, 2021 | 8.60B | 2.25B | 35.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Resources Pharmaceutical Group | 299.99B |
| The United Laboratories International Holdings | 14.70B |
| China Medical System Holdings | 9.14B |
| Simcere Pharmaceutical Group | 8.60B |
| Sunshine Lake Pharma | 3.96B |
| Consun Pharmaceutical Group | 3.80B |
| Sihuan Pharmaceutical Holdings Group | 2.30B |
| CanSino Biologics | 1.19B |